Cellbricks Therapeutics

📍 Berlin, Germany🗓 Founded 2016👥 30 employees💰 Last funded Apr 2025
Biotechnology🌐 cellbricks-therapeutics.com
Website LinkedIn
Cellbricks Therapeutics is a Berlin-based biotech company pioneering the future of regenerative medicine and longevity. Built on deeptech innovation, the company combines proprietary 3D- bioprinting technology with advanced biomaterials and human cells to develop implantable tissue grafts for clinical use. Cellbricks’ mission is to transform healthcare by restoring organ function and replacing damaged tissue with living, functional implants – produced reliably and at scale. For inquiries please contact: Moritz Marschall mm@cellbricks.com
4
Total investors
0
Early stage
0
Mid stage
4
Late stage
2016
Founded

Investors

4 investors
All
Early stage
Mid stage
Late stage
Investor geography3 countries
Germany
2
Turkey
1
United States
1
Investor activity2024–2025 · investors recorded per year
2024220252
Recent (last 2y)Earlier
Frequently asked questions
Who invested in Cellbricks Therapeutics?
Cellbricks Therapeutics has 4 investors on record on gritt.io and 4 late-stage investors.
When did Cellbricks Therapeutics last raise funding?
The most recent investment in Cellbricks Therapeutics recorded on gritt.io was in April 2025.
When was Cellbricks Therapeutics founded?
Cellbricks Therapeutics was founded in 2016.
What industry is Cellbricks Therapeutics in?
Cellbricks Therapeutics operates in Biotechnology. Find similar Biotechnology investors on gritt.io.
Where is Cellbricks Therapeutics based?
Cellbricks Therapeutics is headquartered in Berlin, Germany.